Free Trial

electroCore (ECOR) Competitors

electroCore logo
$6.72 +0.28 (+4.26%)
As of 03:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ECOR vs. ELMD, PROF, LAKE, INGN, DRTS, AVR, BWAY, SKIN, OBIO, and TLSI

Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include Electromed (ELMD), Profound Medical (PROF), Lakeland Industries (LAKE), Inogen (INGN), Alpha Tau Medical (DRTS), Anteris Technologies Global (AVR), BrainsWay (BWAY), Beauty Health (SKIN), Orchestra BioMed (OBIO), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

electroCore vs.

electroCore (NASDAQ:ECOR) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Electromed has a net margin of 11.34% compared to electroCore's net margin of -54.40%. Electromed's return on equity of 15.71% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
electroCore-54.40% -154.45% -69.16%
Electromed 11.34%15.71%13.37%

Electromed has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
electroCore$25.18M1.92-$18.83M-$1.62-4.16
Electromed$59.63M3.41$5.15M$0.7531.71

electroCore received 145 more outperform votes than Electromed when rated by MarketBeat users. However, 91.67% of users gave Electromed an outperform vote while only 62.55% of users gave electroCore an outperform vote.

CompanyUnderperformOutperform
electroCoreOutperform Votes
167
62.55%
Underperform Votes
100
37.45%
ElectromedOutperform Votes
22
91.67%
Underperform Votes
2
8.33%

electroCore has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500. Comparatively, Electromed has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.

26.7% of electroCore shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 19.7% of electroCore shares are held by company insiders. Comparatively, 14.0% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

electroCore presently has a consensus target price of $25.50, indicating a potential upside of 278.56%. Electromed has a consensus target price of $38.00, indicating a potential upside of 59.80%. Given electroCore's higher possible upside, research analysts plainly believe electroCore is more favorable than Electromed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

In the previous week, electroCore had 1 more articles in the media than Electromed. MarketBeat recorded 3 mentions for electroCore and 2 mentions for Electromed. Electromed's average media sentiment score of 1.01 beat electroCore's score of 0.43 indicating that Electromed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
electroCore
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Electromed
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Electromed beats electroCore on 14 of the 19 factors compared between the two stocks.

Remove Ads
Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ECOR vs. The Competition

MetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$48.25M$3.31B$5.61B$7.72B
Dividend YieldN/A1.63%5.33%4.03%
P/E Ratio-3.6714.5723.5718.60
Price / Sales1.9243.64369.1789.09
Price / CashN/A44.0938.1734.64
Price / Book5.433.356.794.10
Net Income-$18.83M$94.03M$3.20B$247.10M
7 Day Performance-9.34%-3.80%-5.59%-4.02%
1 Month Performance-55.74%-12.87%-0.35%-6.40%
1 Year Performance9.17%-20.84%7.66%-2.12%

electroCore Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ECOR
electroCore
2.6721 of 5 stars
$6.73
+4.3%
$25.50
+279.2%
+4.5%$48.37M$25.18M-3.6750Short Interest ↑
ELMD
Electromed
1.2293 of 5 stars
$24.45
-1.1%
$38.00
+55.4%
+44.5%$209.22M$59.63M32.60160Analyst Downgrade
PROF
Profound Medical
2.2897 of 5 stars
$6.81
flat
$14.25
+109.3%
-29.1%$204.57M$10.68M-5.08150
LAKE
Lakeland Industries
4.7571 of 5 stars
$21.09
+12.4%
$28.33
+34.3%
+10.7%$200.33M$151.82M-234.331,800Positive News
Gap Up
High Trading Volume
INGN
Inogen
2.6339 of 5 stars
$7.37
+0.3%
$7.00
-5.0%
-15.7%$195.53M$335.71M-3.281,030
DRTS
Alpha Tau Medical
2.0724 of 5 stars
$2.70
+3.4%
$8.00
+196.3%
-13.2%$188.80MN/A-6.2880Short Interest ↑
News Coverage
AVR
Anteris Technologies Global
N/A$5.12
-1.2%
$16.50
+222.3%
N/A$184.44M$2.71M0.00138High Trading Volume
BWAY
BrainsWay
3.0907 of 5 stars
$9.77
-1.4%
$13.17
+34.8%
+75.8%$183.94M$41.02M97.71120Short Interest ↑
Gap Down
SKIN
Beauty Health
1.9244 of 5 stars
$1.41
+7.6%
$2.50
+77.3%
-70.3%$175.01M$334.29M-3.361,030
OBIO
Orchestra BioMed
1.9169 of 5 stars
$4.57
+1.3%
$15.40
+237.0%
-16.5%$173.72M$2.65M-2.844Gap Up
TLSI
TriSalus Life Sciences
3.478 of 5 stars
$5.67
+0.5%
$11.56
+103.9%
-42.4%$172.90M$26.89M-2.28106Earnings Report
Analyst Forecast
News Coverage
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:ECOR) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners